c ongenital hypogonadotropic hypogonadism (HH) is a rare disorder characterized by incomplete or absent puberty caused by the lack or deficient number of hypothalamic gonadotropin-releasing hormone (GnRH) neurons, disturbed secretion or action of GnRH, or both (1) . Various patterns of inheritance have been observed in association with this condition, including X-linked, autosomal dominant, and autosomal recessive, as well as di-and oligogenic inheritance (2) (3) (4) . Mutations in several genes, including KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, WDR11, GNRHR, GNRH1, KISS1R, KISS1, TAC3, and TACR3 (5, 6) , have been shown to cause the disorder. In the majority of cases, however, the molecular genetic cause remains unresolved, implying the existence of additional genes underlying the condition (7). We have described the phenotypic and genotypic features of Finnish patients with Kallmann syndrome (KS) (8) . A molecular genetic cause was obtained for ~40% of Finnish KS patients, suggesting the presence of mutations in genes not yet implicated to underlie this syndrome.
Semaphorins are a class of secreted and membrane proteins that act as axonal growth cone guidance molecules. Sema3A-and Sema7A-mutant mice have a reduced number of GnRH neurons in their brains, with Sema3A being essential for the patterning of vomeronasal axons (9) , whereas in Sema7A mutants, the olfactory system appears to remain unaffected (10) . Thus, SEMA3A is a good candidate gene for KS and SEMA7A for normosmic HH (nHH). Two recent studies have suggested a role for SEMA3A mutations in the pathogenesis of KS in humans (11, 12) . However, studies on SEMA7A in patients with congenital HH have not yet been reported.
Our objective in the current work was to investigate whether mutations in these two candidate genes, SEMA3A and SEMA7A, are present in Finnish patients with congenital HH.
RESULTS
Overall, the mutation screening of SEMA3A and SEMA7A revealed few nonsynonymous variants. The nonsynonymous variants identified and the patients' phenotypes are presented in Table 1 Arg148Trp) , was found in SEMA7A in a male patient with congenital nHH. The variant was predicted to be "probably damaging" by PolyPhen-2 (score: 1.00). A heterozygous nonsense variant, c.1167C>A (p.Cys389*) in KISS1R (NM_032551.4), a gene implicated in autosomal recessive nHH, was identified previously in the same patient, but no other mutation was found when the coding region, promoter region, and the cDNA of KISS1R were Sanger sequenced. Neither of the mutations was present in 200 controls, and both were reported once in the EVS database: SEMA7A Arg148Trp 1/12986 and KISS1R Cys389* 1/10952 chromosomes. Another missense variant in SEMA7A, c.1421G>A (p.Arg474Gln), was identified in a KS patient who also had a KAL1 mutation deleting the last base of exon 8 and the first three bases of the following intron (g.2357_2360delAgta), thus disrupting a splice site (8) . The Arg474Gln variant was predicted by PolyPhen-2 to be "probably damaging" with a score of 0.999. The variant is absent in the EVS database, but several other amino acid substitutions have been reported in the same position (p.Arg474Leu, p.Arg474Pro, and p.Arg474Trp), suggesting that some variation is tolerated in this amino acid position. We identified three missense changes (Val435Ile, Asn153Ser, and Asn418Ser) in SEMA3A in three probands with KS. Two of these variants (Val435Ile and Asn153Ser) were also reported by Hanchate et al. (12) . The Asn153Ser variant has been shown to cause reduced signaling activity in the GN11 cell line, whereas the Val435Ile variant results in impaired secretion of semaphorin 3A, suggesting that these two mutations have a pathogenic effect (12) . Notably, two probands with SEMA3A variants (Asn153Ser and Asn418Ser) also had previously described truncating mutations in FGFR1 (8) . Di-/oligogenic inheritance of HH has been continuously reported (2-4), and it seems possible that SEMA3A mutations might have a role in modifying the KS phenotype, although conclusive evidence is still lacking. For example, Young et al. (11) proposed that the heterozygous SEMA3A deletion might be sufficient to cause the disease phenotype because no other mutations were detected and the deletion cosegregated in the family with the apparently autosomal dominantly transmitted KS phenotype. On the other hand, Hanchate et al. (12) suggested that monoallelic mutations in SEMA3A are not sufficient to cause the disease phenotype based on the finding that all the missense variants they detected were reported in the EVS database, some were also found in healthy controls, and some of the patients also carried mutations in other genes implicated in KS. In none of the patients in our study, did mutations in SEMA3A seem to be the sole cause of the disorder as we only found heterozygous variants that are also present in healthy control individuals. The third patient, with the Val435Ile variant in SEMA3A and without other detected mutations in the known HH genes, most likely still has at least one unidentified mutation contributing to the disorder.
DISCUSSION
In the same vein, we wanted to screen in our patients another semaphorin gene, SEMA7A, which has recently been shown 
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Articles to have a role in the migration of GnRH neurons in mice (10) . SEMA7A is able to promote axon outgrowth by signaling through integrin receptors containing the β1 subunit (13) and promotes directional migration of GnRH neurons through β1-integrin-dependent cell adhesion (10) . β1-integrin signaling was also recently shown to be involved in the development of GnRH neuron axonal projections to the median eminence in mice (14) . Sema7A −/− adult mice have a 30% reduction of GnRH-1 cells in their brains compared with wild-type mice, and innervation of the median eminence by GnRH-1 neuron fibers is also clearly reduced (10). This phenotype seems to be the result of defective GnRH-1 neuron migration, which ultimately leads to reduced fertility in Sema7A −/− mice, whereas the development of the olfactory system appears to remain unaffected (10) . We identified two rare variants in SEMA7A, both of which are predicted to be probably damaging by PolyPhen-2. Both of the variants are located in the conserved Sema domain of SEMA7A (Figure 1) , which is responsible for receptor-binding specificity of the protein (15), although they are not located in the arginine-glycine-aspartate motif (amino acids 267-269) recognized by certain integrin receptors (16) . It seems likely that the identified mutations alone are not sufficient to cause the disease phenotype, although they may contribute to it. Interestingly, one of the patients with a rare variant in SEMA7A also had a heterozygous nonsense mutation in KISS1R, a gene implicated in autosomal recessive nHH (17) , bringing forth the possibility of di-/oligogenic inheritance. Whether or not this KISS1R variant is in homozygous or compound heterozygous state capable of causing HH, however, is still unclear.
Taken together, the role of defective semaphorin signaling in GnRH deficiency has recently gained interest. Our results show that mutations in SEMA3A and SEMA7A are rare among Finnish patients but might have a role in modifying the disease phenotype. Further studies in different populations are warranted.
METHODS
Fifty patients with HH who were previously diagnosed on a basis of (i) clinical signs and symptoms of hypogonadism (absent puberty, infertility, and/or decreased libido), (ii) low sex steroid levels in association with inappropriately low or normal gonadotropin levels, and subnormal or normal response to GnRH stimulation test, (iii) otherwise normal anterior pituitary function, (iv) normal radiological imaging of the hypothalamic and pituitary areas, and in case of KS, (v) defective sense of smell detected by formal testing (UPSIT score <5th percentile of age; University of Pennsylvania Smell Identification Test; Sensonic, Haddon Heights, NJ), and/or absent or rudimentary olfactory bulbs in magnetic resonance imaging, were screened for mutations in SEMA3A and SEMA7A. Patients were enrolled from all five university hospitals in Finland. Of them, 30 patients (27 men and 3 women), including 19 KS patients (18 men and 1 woman), 9 nHH patients (7 men and 2 women), and 2 men with adult onset HH, were not found to have mutations in known HH genes (8, 18) . In addition, 20 HH patients were previously described to have mutation(s) in KAL1 (NM_000216.2; 3 patients), FGFR1 (NM_023110.2; 12 patients), GNRHR (NM_000406.2; 4 patients), or CHD7 (NM_017780.2; 1 patient) (8, (18) (19) (20) (21) .
The coding exons and exon-intron boundaries of SEMA3A (NM_006080.2) and SEMA7A (NM_003612.3) were PCR amplified from the genomic DNA of the patients. PCR products were purified with ExoSAP-IT treatment (Amersham Biosciences, Piscataway, NJ) and bidirectionally sequenced using the ABI BigDyeTerminator Cycle Sequencing Kit (v3.1) and ABI Prism 3730xl DNA Analyzer automated sequencer (Applied Biosystems, Foster City, CA). The sequences were aligned and read with Sequencher 4.9 software (Gene Codes, AnnArbor, MI). All primer sequences and PCR conditions are available upon request. Exon 4 of SEMA7A was also sequenced in 200 controls. The minor allele frequencies of the identified variants were checked in the EVS database, and the effects of the identified SEMA7A variants were predicted with the web version of PolyPhen-2 software (22) .
This study was performed with appropriate permissions from the Ethics Committee (E7) of the Helsinki University Central Hospital. Written informed consents were obtained from the participants, and also from their guardian if the participant was less than 16 y of age. 
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